SDS Biotech's sphaerotheca amyloliquefaciens AT-332 to be registered in China for first time

Summary: The sphaerotheca amyloliquefaciens AT-332 5 billion CFU/g WG from SDS Biotech will be approved for registration in China for the first time. The product will be registered to prevent and treat strawberry powdery mildew.On 28 Aug., the Instit...

Fungicides China News 202009

www.cnchemicals.com